GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,114,599 | +40.2% | 183,577 | +68.2% | 0.01% | +50.0% |
| Q2 2023 | $6,499,743 | +11.9% | 109,166 | +6.4% | 0.01% | 0.0% |
| Q1 2023 | $5,810,188 | -22.2% | 102,581 | +2.0% | 0.01% | -25.0% |
| Q4 2022 | $7,467,922 | +4.2% | 100,551 | -16.4% | 0.01% | 0.0% |
| Q3 2022 | $7,166,000 | -1.6% | 120,289 | -7.3% | 0.01% | 0.0% |
| Q2 2022 | $7,281,000 | -16.2% | 129,703 | +10.2% | 0.01% | +14.3% |
| Q1 2022 | $8,685,000 | +1.0% | 117,715 | -1.1% | 0.01% | +40.0% |
| Q4 2021 | $8,596,000 | -20.1% | 119,060 | -15.2% | 0.01% | -16.7% |
| Q3 2021 | $10,759,000 | -21.4% | 140,418 | -21.7% | 0.01% | -14.3% |
| Q2 2021 | $13,692,000 | +32.7% | 179,297 | +7.1% | 0.01% | +40.0% |
| Q1 2021 | $10,321,000 | -6.6% | 167,370 | -1.2% | 0.01% | 0.0% |
| Q4 2020 | $11,045,000 | +18.2% | 169,337 | -10.3% | 0.01% | -16.7% |
| Q3 2020 | $9,348,000 | +35.0% | 188,791 | +30.1% | 0.01% | +20.0% |
| Q2 2020 | $6,924,000 | +43.2% | 145,141 | +27.7% | 0.01% | +25.0% |
| Q1 2020 | $4,834,000 | -43.7% | 113,640 | -22.0% | 0.00% | -33.3% |
| Q4 2019 | $8,580,000 | +52.5% | 145,718 | +32.4% | 0.01% | +20.0% |
| Q3 2019 | $5,625,000 | +14.0% | 110,031 | -5.7% | 0.01% | +25.0% |
| Q2 2019 | $4,934,000 | -22.6% | 116,669 | -9.6% | 0.00% | -33.3% |
| Q1 2019 | $6,378,000 | -10.3% | 129,084 | -21.4% | 0.01% | -14.3% |
| Q4 2018 | $7,107,000 | -1.7% | 164,194 | +28.9% | 0.01% | +16.7% |
| Q3 2018 | $7,228,000 | -0.9% | 127,359 | -11.9% | 0.01% | -14.3% |
| Q2 2018 | $7,296,000 | -1.9% | 144,582 | -3.2% | 0.01% | 0.0% |
| Q1 2018 | $7,440,000 | +30.6% | 149,347 | +7.8% | 0.01% | +40.0% |
| Q4 2017 | $5,695,000 | +4.9% | 138,590 | -24.1% | 0.01% | 0.0% |
| Q3 2017 | $5,428,000 | +28.3% | 182,665 | +43.1% | 0.01% | +25.0% |
| Q2 2017 | $4,230,000 | +12.0% | 127,631 | +0.0% | 0.00% | +33.3% |
| Q1 2017 | $3,778,000 | +2.3% | 127,572 | -14.3% | 0.00% | -25.0% |
| Q4 2016 | $3,694,000 | -7.5% | 148,878 | -15.8% | 0.00% | 0.0% |
| Q3 2016 | $3,994,000 | -4.5% | 176,917 | +0.8% | 0.00% | -20.0% |
| Q2 2016 | $4,182,000 | -21.3% | 175,481 | -21.6% | 0.01% | -16.7% |
| Q1 2016 | $5,313,000 | +86.6% | 223,711 | +118.6% | 0.01% | +100.0% |
| Q4 2015 | $2,847,000 | -30.0% | 102,353 | -48.0% | 0.00% | -40.0% |
| Q3 2015 | $4,068,000 | +10.3% | 196,918 | +37.1% | 0.01% | +25.0% |
| Q2 2015 | $3,687,000 | +134.2% | 143,674 | +130.4% | 0.00% | +100.0% |
| Q1 2015 | $1,574,000 | -34.5% | 62,372 | -38.3% | 0.00% | 0.0% |
| Q4 2014 | $2,402,000 | +19.7% | 101,045 | -1.0% | 0.00% | 0.0% |
| Q3 2014 | $2,007,000 | -42.6% | 102,015 | -30.2% | 0.00% | -33.3% |
| Q2 2014 | $3,496,000 | +186.3% | 146,153 | +218.1% | 0.00% | +200.0% |
| Q1 2014 | $1,221,000 | -14.3% | 45,941 | -34.9% | 0.00% | 0.0% |
| Q4 2013 | $1,424,000 | +108.2% | 70,542 | +80.1% | 0.00% | 0.0% |
| Q3 2013 | $684,000 | -53.7% | 39,170 | -55.3% | 0.00% | 0.0% |
| Q2 2013 | $1,476,000 | +570.9% | 87,597 | +485.2% | 0.00% | – |
| Q1 2013 | $220,000 | – | 14,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |